Esperance Pharmaceuticals Raises $7.5M

Baton Rouge, Louisiana-based Esperance Pharmaceuticals has closed on $7.5 million in Series B financing. Sanofi led the Series B funding with an investment of $4.5 million. Louisiana Fund I, Themelios Ventures, Research Corporation Technologies and Advantage Capital Partners/Louisiana Technology Fund also contributed to the round. The cash infusion will help the company continue clinical development of its cancer-targeting drug candidate.

North AmericaUSBriefs